Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV single-arm study of DexULac in mild to moderate onychomycosis
2024-520381-62-00Phase 4Authorised
- Sponsor
- Laboratorio Reig Jofre, S.A.
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of urea + lactic acid + dexpanthenol in onychomycosis, sponsored by Laboratorio Reig Jofre, S.A. Primary endpoint: Change in Onychomycosis Severity Index. Planned start Jul 2025; status: authorised.
02
Drugs
urea + lactic acid + dexpanthenol
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2024-520381-62-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520381-62-00.